Free Trial

Kinaxis (TSE:KXS) Shares Cross Above Fifty Day Moving Average - Here's What Happened

Kinaxis logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Kinaxis shares crossed above their 50-day moving average (50‑day = C$136.52), trading as high as C$141.94 and last at C$140.14 on volume of 146,761.
  • Analysts remain generally positive—six Buy ratings and one Hold—giving a consensus “Moderate Buy” with an average target of C$208.67, although several firms recently trimmed targets into the ~C$180–C$203 range.
  • Fundamentals show a C$3.88 billion market cap, last-quarter EPS of C$0.93 on C$189.95 million revenue, and a relatively high valuation with a P/E of 57.2.
  • Five stocks we like better than Kinaxis.

Kinaxis Inc. (TSE:KXS - Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$136.52 and traded as high as C$141.94. Kinaxis shares last traded at C$140.14, with a volume of 146,761 shares traded.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Royal Bank Of Canada dropped their target price on shares of Kinaxis from C$235.00 to C$200.00 and set an "outperform" rating for the company in a research report on Monday, January 26th. Scotiabank decreased their price target on shares of Kinaxis from C$240.00 to C$200.00 and set an "outperform" rating for the company in a research note on Wednesday, February 4th. TD Securities decreased their price target on shares of Kinaxis from C$229.00 to C$200.00 and set a "buy" rating for the company in a research note on Friday, March 6th. Canadian Imperial Bank of Commerce upgraded shares of Kinaxis from a "hold" rating to an "outperform" rating and raised their price objective for the stock from C$201.00 to C$203.00 in a report on Monday, December 15th. Finally, BMO Capital Markets cut their price objective on Kinaxis from C$225.00 to C$180.00 in a research report on Monday, March 2nd. Six research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to data from MarketBeat.com, Kinaxis presently has an average rating of "Moderate Buy" and an average target price of C$208.67.

Read Our Latest Stock Analysis on KXS

Kinaxis Trading Up 1.8%

The stock has a market cap of C$3.88 billion, a P/E ratio of 57.20, a PEG ratio of 3.60 and a beta of 0.76. The company has a current ratio of 1.97, a quick ratio of 2.29 and a debt-to-equity ratio of 11.39. The stock's fifty day moving average price is C$136.52 and its 200 day moving average price is C$163.14.

Kinaxis (TSE:KXS - Get Free Report) last released its earnings results on Wednesday, March 4th. The company reported C$0.93 earnings per share for the quarter. Kinaxis had a net margin of 12.90% and a return on equity of 16.46%. The firm had revenue of C$189.95 million for the quarter. Equities research analysts expect that Kinaxis Inc. will post 4.2526231 earnings per share for the current year.

About Kinaxis

(Get Free Report)

Kinaxis Inc is a Canada-based provider of software solutions for sales and operations planning (S&OP) and supply chain management. The firm's flagship RapidResponse product is offered on the cloud. Its capabilities include consequence evaluation and alerting, responsibility-based collaboration, high-speed analytics, and scenario simulation. Kinaxis's S&OP solution capabilities include supply and demand planning, capacity and inventory planning, and inventory management. The firm has operations in North America, Europe, and Asia-Pacific regions.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Kinaxis Right Now?

Before you consider Kinaxis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kinaxis wasn't on the list.

While Kinaxis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines